A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IFN-alpha / alpha-interferon

[Related PubMed/MEDLINE]
Total Number of Papers: 134
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IFN-alpha  (>> Co-occurring Abbreviation)
Long Form:   alpha-interferon
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Viral genes and cellular markers associated with neurological complications during herpesvirus infections. CNS, EHV-1, gD, IFN-gamma, IL-10, IL-1beta
2013 Immunotherapeutic benefit of alpha-interferon (IFNalpha) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients. IAP, IFA
2012 Interferon-induced obsessive-compulsive symptoms in malignant melanoma. ---
2012 Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with alpha-interferon plus a nucleos(t)ide analog. HBsAg
2012 [Sustained efficacy of alpha-interferon therapy combined with Yixuesheng Capsule in treatment of chronic hepatitis B]. ---
2010 Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. BALF, IL-12, MLN, NK
2009 A single substitution in amino acid 184 of the NP protein alters the replication and pathogenicity of H5N1 avian influenza viruses in chickens. HPAI, IFN-gamma, iNOS
2009 Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells. 2'5'AS, ds
2008 Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B. CHB, ELISA, HBeAg, HBV, NPV, PPV
10  2007 An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities. ---
11  2007 Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas. ELISA, sFasL
12  2007 Enhancing the anti-angiogenic action of histone deacetylase inhibitors. HDACIs, TSA
13  2006 Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon. HCV
14  2005 Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy. IL-2
15  2004 Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy. HBeAg, LAM
16  2004 Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis. OS, RR
17  2004 Safety of interferon beta treatment for chronic HCV hepatitis. ---
18  2003 Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. ATP, HU, IMF, PDGF, PPMF
19  2003 Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis. HCV, LP
20  2002 Introduction of lamivudine for the treatment of chronic hepatitis B: expected clinical and economic outcomes based on 4-year clinical trial data. CHB
21  2001 Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis of some predictive factors for the response. IFN
22  2001 Interferon-alpha therapy in idiopathic thrombocytopenic purpura. ITP
23  2001 Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection. ---
24  2001 Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following alpha-interferon therapy. 7S-IV, HIC, P-III-P
25  2001 [Persistence of type 1 human immunodeficiency virus (HIV-1) in MT-4 cells in presence of alpha-interferon]. ---
26  2000 Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. HCC, TAE
27  2000 Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study. IL-2, PVI
28  1998 Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats. IDDM, rIFN-alpha
29  1998 Alpha-interferon inhibits the development of diabetes in NOD mice. rIFN-alpha
30  1998 Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B. HBeAg-negative, HBsAg-positive, HBV
31  1998 Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis. CML, RT-PCR
32  1998 Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. HBsAg, ICD, nIFN-beta, rIFN-gamma, s.c
33  1998 Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma. CRA
34  1998 [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea]. HU
35  1997 Alpha-Interferon for the treatment of idiopathic sudden sensorineural hearing loss. 2,5A-S, ISSHL
36  1997 Behcet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms. BD, CML
37  1997 Biologic activities of natural and synthetic type I interferons. ---
38  1997 Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen. CRA, PSA, TGF-beta1
39  1997 Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer. IL-2, LAK, TNF-alpha
40  1997 High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease. IFN, TM
41  1997 [Lymphomatoid granulomatosis--remission induction with interferon-alpha 2b]. LG
42  1996 Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. CsA, KT
43  1996 Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma. HCC
44  1996 Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. HBV, HCV
45  1996 High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. BPCs, ECP, LCP, Ph, TBI
46  1996 Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. HCV, PBMC, PCR
47  1996 Serum alpha-interferon in lower respiratory tract infections of children. ---
48  1995 Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. ALL, allo-CT, BMT, CML, GVHD, PBL, TCD
49  1995 Autoimmune thyroid dysfunctions in hematologic malignancies treated with alpha-interferon. ---
50  1995 Behcet's disease induced by interferon therapy for chronic myelogenous leukemia. BD, CML, MCTD
51  1995 Interferon-alpha hybrids. ---
52  1995 Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group. ALT, CI
53  1995 The role of natural killer cells in the treatment of chronic myeloid leukemia. BMT, CML, IL-2, NK
54  1995 Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. HBVMN, s.c
55  1995 [Expression of GP160 mRNA in renal cell carcinoma: an attempt to predict the sensitivity of IFN-alpha therapy]. RC, RT-PCR
56  1994 A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration. ---
57  1994 Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance. DOX, p-gp, VPL
58  1994 Endocrine tumors of the gastrointestinal tract: systemic treatment. ---
59  1994 Interferon alpha and intracytoplasmic free calcium in hairy cell leukemia cells. HCL
60  1994 Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells. HCL
61  1994 Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase. FUra, PO-dUrd, TP
62  1994 Reversible cognitive decline during high-dose alpha-interferon treatment. ALS
63  1994 Synergistic inhibition of T-lymphoblastic leukemic CCRF-CEM cell growth by gallium and recombinant human alpha-interferon through action on cellular iron uptake. ---
64  1994 [Molecular diagnosis and therapeutic strategy for Philadelphia chromosome-positive acute leukemia]. ISGs
65  1993 An episode of silent thyroiditis in a patient with chronic thyroiditis and papillary adenocarcinoma following alpha interferon treatment for hepatitis C. CT
66  1993 Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study. CML, CP, LTC, LTC-IC, Ph
67  1993 Case report: silent thyroiditis developed during alpha-interferon therapy. ---
68  1993 Characterization of murine Caraparu Bunyavirus liver infection and immunomodulator-mediated antiviral protection. IFN-beta, IFN-gamma, MST
69  1993 Effect of alpha-interferon on anti-alpha-fetoprotein-monoclonal-antibody targeting of hepatoma. AFP, mAb
70  1993 Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. IFN-gamma, TIL
71  1993 Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C. ---
72  1993 Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events. EGF
73  1993 Low dose cyclophosphamide, alpha-interferon and continuous infusions of interleukin-2 in advanced renal cell carcinoma. CY, IL-2, RCC
74  1993 Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance. DOX, TAM
75  1993 Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer. ---
76  1992 Altered cytokine production in black patients with keloids. IFN-beta, IFN-gamma, IL-1, IL-2, IL-6, PBMC, TNF-alpha, TNF-beta
77  1992 Immunohistochemical detection of double-stranded-RNA-dependent protein kinase (p68) with a novel monoclonal antibody TJ4C4. A case report of an AIDS-associated Kaposi's sarcoma treated with alpha-interferon. dsRNA, mAb
78  1992 Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. ---
79  1992 Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy. HCL
80  1992 Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. CLL, PBMC
81  1992 Recombinant alpha-interferon inhibits colony formation of bone marrow fibroblast progenitor cells (CFU-F). BFU-E, CFU-GEMM, CFU-GM, CFU-MK
82  1992 Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes. ADR, AZT, M/M, PCR
83  1992 The effects of interleukin 2 and alpha-interferon administration on hepatic drug metabolism in mice. DTP, IFN-gamma, IL-2
84  1992 Transient cytogenetic relapse in a Ph1-positive chronic myelogenous leukemia patient previously treated with alpha-interferon. CML, PCR
85  1991 Alpha-interferon reduces in vivo phosphorylation of P210bcr/abl protein during hemin-induced erythroid differentiation of K-562 cells. CML
86  1991 Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. oTP-1
87  1991 Class I major histocompatibility complex enhancement by recombinant leukocyte interferon in the peripheral blood mononuclear cells and plasma of melanoma patients. ---
88  1991 Interferon-regulated viral replication in chronically HIV1-infected promonocytic U937 cells. ds, TAR
89  1991 Malignant mesothelioma: the antiproliferative effect of cytokine combinations on three human mesothelioma cell lines. IFN-gamma, TNF
90  1991 Sequential chemoimmunotherapy for metastatic melanoma. ---
91  1991 The role of alpha-interferon in patients with human immunodeficiency virus infection. HIV
92  1991 Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. EGFR
93  1990 Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein. RC
94  1990 B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens. BCGF, HCL, HCs
95  1990 Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis. beta 2-MG, CH-NANB, CHB, HAI, IFN-beta, MIU, SGPT
96  1990 Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle. IDO, IFN-gamma
97  1990 Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level. IL-2, LAK, LAKp
98  1990 Long-term alpha-interferon therapy in myelodysplastic syndromes. MDS
99  1990 Lonidamine and human lymphoblastoid alpha interferon in metastatic cancer: a phase I study. ---
100  1990 Recurrent herpes simplex virus type 1 infection precipitated by the impaired production of interleukin-2, alpha-interferon, and cell-mediated cytotoxicity. HSV-1, IL-2